- Home
- WKEY vs ANL Comparison
WKEY vs ANL Comparison
Compare WKEY & ANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WKEY
- ANL
- Stock Information
- Founded
- WKEY 1999
- ANL 2004
- Country
- WKEY Switzerland
- ANL Cayman Islands
- Employees
- WKEY N/A
- ANL N/A
- Industry
- WKEY EDP Services
- ANL
- Sector
- WKEY Technology
- ANL
- Exchange
- WKEY Nasdaq
- ANL Nasdaq
- Market Cap
- WKEY 78.1M
- ANL 73.8M
- IPO Year
- WKEY N/A
- ANL 2023
- Fundamental
- Price
- WKEY $6.41
- ANL $1.63
- Analyst Decision
- WKEY Strong Buy
- ANL Buy
- Analyst Count
- WKEY 1
- ANL 2
- Target Price
- WKEY $4.00
- ANL N/A
- AVG Volume (30 Days)
- WKEY 245.2K
- ANL 12.7K
- Earning Date
- WKEY 06-24-2025
- ANL 08-08-2025
- Dividend Yield
- WKEY N/A
- ANL N/A
- EPS Growth
- WKEY N/A
- ANL N/A
- EPS
- WKEY N/A
- ANL N/A
- Revenue
- WKEY $11,875,000.00
- ANL N/A
- Revenue This Year
- WKEY $18.18
- ANL N/A
- Revenue Next Year
- WKEY $112.51
- ANL N/A
- P/E Ratio
- WKEY N/A
- ANL N/A
- Revenue Growth
- WKEY N/A
- ANL N/A
- 52 Week Low
- WKEY $1.61
- ANL $1.10
- 52 Week High
- WKEY $14.00
- ANL $4.10
- Technical
- Relative Strength Index (RSI)
- WKEY 52.16
- ANL 42.00
- Support Level
- WKEY $6.12
- ANL $1.56
- Resistance Level
- WKEY $8.11
- ANL $1.74
- Average True Range (ATR)
- WKEY 0.61
- ANL 0.15
- MACD
- WKEY -0.08
- ANL -0.01
- Stochastic Oscillator
- WKEY 24.44
- ANL 32.71
About WKEY WISeKey International Holding Ltd
WISeKey International Holding Ltd is a cybersecurity company focused on delivering integrated security solutions for the Internet of Things and digital identity ecosystems. It integrates secure semiconductors, cybersecurity software, and a globally recognized Root of Trust (RoT) into products and services that protect users, devices, data and transactions in the internet-connected world. It has two business segments. The IoT segment, which is the key revenue driver, generates revenue from the sale of semiconductor's secure chips. The mPKI segment generates revenues from Digital Certificates, It derives maximum revenue from IoT segment.
About ANL Adlai Nortye Ltd.
Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.